July 2008
Advertisement
Advertisement
Trending on HCPLive
1
Lp(a)HORIZON, Oral PCSK9s, and 2027 Lipid Trials, with Kausik Ray, MD, MBChB, MPhil
2
Single Dose of CIDEB siRNA Normalizes Liver Fat in MASLD Through 36 Weeks
3
Elebsiran Plus Tobevibart Suppresses HDV RNA in Phase 3 ECLIPSE 1 Trial
4
Sotatercept May Promote Broad Cardiac Remodeling in Addition to Pulmonary Vascular Benefit
5